The pharmaceutical landscape is constantly transforming, with acquisition opportunities emerging as a key driver of growth and expansion. One such opportunity has piqued the interest of industry analysts: Wockhardt, an established Indian biotechnology company with a strong global presence. Wockhardt's portfolio encompasses a diverse range of therap